
HKSEHealthcareMedical - Devices
Latest quote
HK$2.07
+HK$0.175 · +9.23%
Sisram Medical Ltd, an investment holding company headquartered in Caesarea, Israel, since its establishment in 2013, is engaged in the creation, production, and worldwide distribution of a broad spectrum of medical solutions. The company develops and markets energy-based aesthetic devices, minimally invasive therapeutic systems, non-energy-dependent equipment, and cosmeceuticals, reaching markets across Asia Pacific, Europe, North America, Latin America, the Middle East, and Africa. Its comprehensive range of products and treatments addresses numerous conditions, such as hair removal, skin revitalization, acne and scarring, body and facial sculpting, pigment and skin surface refinement, fat transfer procedures, injectable dermal fillers, skin tissue regeneration injectables, personal wellness items, cosmetic dental procedures, transdermal delivery methods, cellulite reduction, stretch mark amelioration, therapy for vascular and pigmented lesions, hydradermabrasion, non-surgical eyelid lifts (blepharoplasty), liposuction, as well as feminine health and sexual well-being applications. Furthermore, the company is involved in the manufacturing, distribution, and sales of general medical apparatus. Sisram Medical's offerings are available under its prominent brand names, which include Alma, Soprano, Harmony, Copulla, Foshion, Accent, and LMNT.
Latest quote
HK$2.07
+HK$0.175 · +9.23%
Regular session · HKT · Market data may be delayed.
Sisram Medical Ltd, an investment holding company headquartered in Caesarea, Israel, since its establishment in 2013, is engaged in the creation, production, and worldwide distribution of a broad spectrum of medical solutions. The company develops and markets energy-based aesthetic devices, minimally invasive therapeutic systems, non-energy-dependent equipment, and cosmeceuticals, reaching markets across Asia Pacific, Europe, North America, Latin America, the Middle East, and Africa. Its comprehensive range of products and treatments addresses numerous conditions, such as hair removal, skin revitalization, acne and scarring, body and facial sculpting, pigment and skin surface refinement, fat transfer procedures, injectable dermal fillers, skin tissue regeneration injectables, personal wellness items, cosmetic dental procedures, transdermal delivery methods, cellulite reduction, stretch mark amelioration, therapy for vascular and pigmented lesions, hydradermabrasion, non-surgical eyelid lifts (blepharoplasty), liposuction, as well as feminine health and sexual well-being applications. Furthermore, the company is involved in the manufacturing, distribution, and sales of general medical apparatus. Sisram Medical's offerings are available under its prominent brand names, which include Alma, Soprano, Harmony, Copulla, Foshion, Accent, and LMNT.
Day range
Current HK$2.07
52-week range
Current HK$2.07
Regular session · HKT · Market data may be delayed.
Sisram Medical Ltd, an investment holding company headquartered in Caesarea, Israel, since its establishment in 2013, is engaged in the creation, production, and worldwide distribution of a broad spectrum of medical solutions. The company develops and markets energy-based aesthetic devices, minimally invasive therapeutic systems, non-energy-dependent equipment, and cosmeceuticals, reaching markets across Asia Pacific, Europe, North America, Latin America, the Middle East, and Africa. Its comprehensive range of products and treatments addresses numerous conditions, such as hair removal, skin revitalization, acne and scarring, body and facial sculpting, pigment and skin surface refinement, fat transfer procedures, injectable dermal fillers, skin tissue regeneration injectables, personal wellness items, cosmetic dental procedures, transdermal delivery methods, cellulite reduction, stretch mark amelioration, therapy for vascular and pigmented lesions, hydradermabrasion, non-surgical eyelid lifts (blepharoplasty), liposuction, as well as feminine health and sexual well-being applications. Furthermore, the company is involved in the manufacturing, distribution, and sales of general medical apparatus. Sisram Medical's offerings are available under its prominent brand names, which include Alma, Soprano, Harmony, Copulla, Foshion, Accent, and LMNT.
Day range
Current HK$2.07
52-week range
Current HK$2.07
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 365.35M USD | 349.11M USD | 359.29M USD | 354.48M USD | 294.29M USD |
| Cost of goods sold | 150.2M USD | 132.43M USD | 139.77M USD | 152.25M USD | 127.43M USD |
| Gross profit | 215.14M USD | 216.68M USD | 219.53M USD | 202.23M USD | 166.86M USD |
| Research and development | 16.86M USD | 15.94M USD | 18.03M USD | 18.02M USD | 15.59M USD |
| Selling, general, and administrative | 165.73M USD | 165.09M USD | 159.44M USD | 128.76M USD | 100.71M USD |
| Operating expenses | 182.59M USD | 181.02M USD | 177.47M USD | 146.78M USD | 116.3M USD |
| Interest income | 962.42K USD | 790K USD | 222K USD | 613K USD | 543K USD |
| Interest expense | 3.25M USD | 2.46M USD | 2.06M USD | 1.97M USD | 2.01M USD |
| Depreciation and amortization | 11.19M USD | 11.23M USD | 14.24M USD | 12.4M USD | 12.29M USD |
| Operating income | 32.56M USD | 35.66M USD | 42.06M USD | 55.44M USD | 50.56M USD |
| Net income | 19.02M USD | 25.13M USD | 31.5M USD | 40.17M USD | 31.25M USD |
Company facts updated Sep 7, 2026.
Recent quarterly results
Recent quarterly results
Cash distributions grouped by calendar year; partial years are marked.
HK$0.126
2025 complete year+80.0% since 2021
2026 partial: HK$0.095
HK$0.07
2,021
HK$0.157
2,022
HK$0.173
2,023
HK$0.158
2,024
HK$0.126
2,025
HK$0.095
2,026*
* Partial calendar year in the available dividend history.
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
Dividend | Aug 26, 2026 | HK$0.095Annual | Aug 27, 2026 | Sep 11, 2026 |
Dividend | Aug 26, 2025 | HK$0.126Annual | Aug 27, 2025 | Sep 9, 2025 |
Dividend | Aug 26, 2024 | HK$0.158Annual | Aug 27, 2024 | Sep 9, 2024 |
Dividend | Aug 24, 2023 | HK$0.173Annual | Aug 25, 2023 | Sep 7, 2023 |
Dividend | Aug 19, 2022 | HK$0.157Annual | Aug 22, 2022 | Sep 2, 2022 |
Dividend | Aug 12, 2021 | HK$0.07Annual | Aug 13, 2021 | Aug 31, 2021 |
Ex-dividend Aug 26, 2026
HK$0.095
Annual
Record Aug 27, 2026 · Payment Sep 11, 2026
Ex-dividend Aug 26, 2025
HK$0.126
Annual
Record Aug 27, 2025 · Payment Sep 9, 2025
Ex-dividend Aug 26, 2024
HK$0.158
Annual
Record Aug 27, 2024 · Payment Sep 9, 2024
Ex-dividend Aug 24, 2023
HK$0.173
Annual
Record Aug 25, 2023 · Payment Sep 7, 2023
Ex-dividend Aug 19, 2022
HK$0.157
Annual
Record Aug 22, 2022 · Payment Sep 2, 2022
Ex-dividend Aug 12, 2021
HK$0.07
Annual
Record Aug 13, 2021 · Payment Aug 31, 2021
Funds reporting this stock among their holdings, ordered by reported position size.
WisdomTree International SmallCap Dividend FundDLS175.75K0.02%1.1B USD0.58%$90.06+0.38%
WisdomTree Dynamic International SmallCap Equity ETFDDLS69.6K0.02%437.37M USD0.48%$46.55+0.37%
WisdomTree Dynamic International Equity FundDDWM54.23K0.00%1.5B USD0.40%$47.60-0.08%
Avantis International Small Cap Value ETFAVDV4.68K—20.38B USD0.36%$113.75+0.07%
WisdomTree International SmallCap Dividend FundDLS
WisdomTree Dynamic International SmallCap Equity ETFDDLS
WisdomTree Dynamic International Equity FundDDWM
Avantis International Small Cap Value ETFAVDVAI-generated and delayed market data for informational and educational purposes only. Not investment advice.